Subtype
AIDS-Related Malignant Neoplasm
CI-CAN-00000427Explore in graph →
12 active trials3 approved drugs
- NCIt
- C4046
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000427Explore in graph →
Clinical trials
66 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (11)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02823327 | Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma | terminated | — | 25 | AIDS Malignancy ConsortiumNETWORK | 1 | May 11, 2025 | clinicaltrials |
| NCT04893018 | NT-I7 for Kaposi Sarcoma in Patients With or Without HIV | terminated | Phase 1 | 8 | Fred Hutchinson Cancer CenterOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT00858793 |
| High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT |
| terminated |
| Phase 1 / Phase 2 |
| 5 |
| Universitätsklinikum Hamburg-EppendorfOTHER |
| 1 |
| Sep 8, 2022 |
| clinicaltrials |
| NCT01752569 | A Study of Selumetinib in Patients With Kaposi's Sarcoma(SCART) | terminated | Phase 1 / Phase 2 | 19 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT00020683 | A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma | terminated | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Oct 18, 2018 | clinicaltrials |
| NCT00036855 | Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00126243 | Efficacy of Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With HIV Associated Non-Hodgkin's Lymphoma | terminated | Phase 2 | 60 | French National Agency for Research on AIDS and Viral HepatitisOTHER_GOV | 1 | Aug 17, 2005 | clinicaltrials |
Data updated 22 days agoSource updated May 11, 2025source: clinicaltrials